Stemming the Tide of Type 2 Diabetes: Bring on the "big Guns"

Obesity

Volumn 18, Issue 6, 2010, Pages 1065-1067

  Buchanan, Thomas A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT;

CELL FUNCTION; CELL PROTECTION; CLINICAL EFFECTIVENESS; EPIDEMIOLOGICAL DATA; FOLLOW UP; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; REVIEW; RISK REDUCTION; WEIGHT REDUCTION; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; EPIDEMIC; PATHOLOGY; PHYSIOLOGY; PREDIABETIC STATE; PREVENTIVE MEDICINE; PROCEDURES; RISK FACTOR; CLINICAL TRIAL; DRUG EFFECT; EDITORIAL; METHODOLOGY;

CLINICAL TRIALS AS TOPIC; CYTOPROTECTION; DIABETES MELLITUS, TYPE 2; DISEASE OUTBREAKS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN-SECRETING CELLS; PREDIABETIC STATE; PREVENTIVE MEDICINE; RISK FACTORS;

EID: 77952901268     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.111     Document Type: Review

References (7)

1. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
2. Tuomilehto J, Lindstrom J, Eriksson JG, et al., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
3. Buchanan TA, Xiang AH, Peters RK, et al., Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002; 51: 2796-2803.
4. DREAM Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: randomised controlled trial. Lancet 2006; 368: 1096-1105.
5. Diabetes Prevention Program Research Group. Effects of withdrawal from metformin on the development of diabetes in the Diabetes Prevention Program. Diabetes Care 2003; 26: 977-980.
6. Chiasson JL, Josse RG, Gomis R, et al., Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002; 359: 2072-2077.
7. Buchanan TA,. (How) can we prevent type 2 diabetes? Diabetes 2007; 56: 1502-1507.